All episodes
What Next for LDTs? A Conversation with Sarah Overton of Velsera
AI’s Quiet Revolution in the Pharma Supply Chain with Chris Petersen, Scientist.com
We've Been Misclassifying Childhood AML for Years: Jeffery Klco, St. Jude's
Aaron Viny: A 21-Year Leukemia Survivor on the Frontlines of Epigenetic Cancer Research
Toward Disease Sub-typing with Ben Busby, DNAnexus
Synthetic Biology Ready for Its ChatGPT Moment: A Preview of SynBioBeta 2025 with John Cumbers
Beyond the Parts List: Chris Mason and Simon Fredriksson on Mapping the Immune System in Space and Cancer with Cell Surface Proteomics
DNA Is Still Where It's At: Christian Henry, CEO of PacBio, on Watershed Year in 2024
A New Sequencing Technology Has Entered the World: Keith Robison Reviews AGBT and New Tech in our Annual Sequencing--er, Multi-Omics Show
Unlocking the Future of Forensic Genetics with Mirna Ghemrawi
Public Science in Peril: Hank Greely of Stanford on Funding, Fishing, and the Fight for Knowledge
Breaking the ‘Undruggable’ Barrier with AI and Synthetic Biology: Eswar Iyer, CEO of Aikium
"They're not cutting a branch. They're cutting the whole tree." Laura Hercher Defends DEI in Genomic Research and Medicine
Early Detection for Lung Cancer with Susan Tousi, DELFI Diagnostics
Big RNA with Brendan Frey of Deep Genomics
Genome Informatics in the Age of AI With Ben Busby, DNAnexus
AI & the Future of Genetic Testing: Ezra Cohen, CMO of Tempus
PredxBio and the Promise of Spatially Intelligent Biology
Surprise: Our Most Popular Show of 2024 Was on Genomic AI
New Startup Launches Epigenetic Screening: Mohamad Takwa, CEO, Epigenica
AI Powered Multiomics: Joachim Schmid on Data Analysis at Illumina
Renowned GI Oncologist Discusses MRD Testing and the Future of Cancer Detection
Precision Medicine Then and Now: We Talk with the Retiring President of the Personalized Medicine Coalition, Ed Abrahams
MicroRNA: A New Era in Biomarker Discovery with Tim Williams and Paola Ulivi
Somatic Genomics: A Revolution in Biology with Jacob Rubens
Exploring the Future of Single Cell Technology with Mauro Muraro, CEO, Single Cell Discoveries
Grail and Verily Alum on Billion Dollar Startup Bringing AI to Drug Development: A Discussion with Vik Bajaj
Singular Genomics Introduces a Dual-Purpose Platform Capable of Both NGS and Spatial Multiomics: Drew Spaventa, CEO & Founder
The Evolving Future of Genetic Counseling with Ellen Matloff, CEO, MyGeneCounsel
As Sequencing Continues to Scale, Volta Labs Improves Sample Prep: Udayan Umapathi, CEO
What’s Next for Large-Scale Proteomics? With Chris Whelan, Janssen
Will this At-Home Blood Collection Device Transform Medicine? Ben Casavant, Tasso
Geneticist Kevin Mitchell Attempts to Naturalize Free Will in New Book
ctDNA Testing Could Lead to New Ways of Staging Cancer Patients, Says Ben Weinberg, MedStar Georgetown
14th Season Opener: Michael Levin on ‘The New Biology’
The Success of ctDNA Testing in Colorectal Cancer: Adham Jurdi, Natera
Henrik Zetterberg on the Current Excitement Around Alzheimer’s Research
The Reboot of Consumer Genomics? with Kian Sadeghi, Nucleus Genomics
From Geospatial to Biospatial: Avi Veidman of Nucleai
New Proteomics Technology Brings Unprecedented Sensitivity and Scale: Yuling Luo, CEO, Alamar Bio
Diagnostic Trends in 2024 with Mara Aspinall, Illumina Ventures
The Actionable Epigenome with Bret Barnes, Illumina
Not All Prenatal Screens Are the Same: Jennifer Hoskovec, Billion to One
Harvard's Marc Lipsitch on the New White House Policy Regulating Risky Pathogen Research
Liquid Biopsy Goes Beyond Cancer: Diana Abdueva and Maggie Louie, Aqtual
Cell Therapy Will Transform Medicine as We Know It, Says Jason Bock, CTMC
Two Industry Leaders on Dealing with the Growing Complexity of Genomic Cancer Data
Single Cell Spatial Proteomics with Filip Karlsson, Pixelgen
The Precision Medicine Optimist: Damon Hostin, Illumina
An Ethics First Approach to Genetic Research and Drug Development with Sarah LeBaron von Baeyer
How Do You Train Genomics AI? On Natural Selection Itself, Says VP of Illumina’s AI Lab, Kyle Farh
The Pre-Symptomatic Space with Patrick Short, Sano Genetics
Systemwide Implementation of Precision Medicine at UCHealth with David Kao
Is this New Tech a Game Changer for Spatial Biology?
Synthetic Biology in 2024 with John Cumbers
Illumina Scales Variant Calling and Genome Interpretation to Improve Gap in Genetic Testing with Sam Strom
The Renaissance in DNA Synthesis Continues: Cosimo Ducani, CEO, Moligo
Jennifer Wipf of Ginkgo Bioworks on RNA Therapeutics and Cell Therapy
Precision Medicine for Dogs: Christina Lopes, OneHealth
Taking Gene Therapy to the Next Level: Rahul Kakkar of Tome
Christian Henry of PacBio on Long Reads at Scale, Next Moves
Robert Michel, Editor at The Dark Report, on Gap in Genetic Testing
Turning to Next Gen Proteomics for Novel Biomarkers: Jon Brudvig and Bruce Wilcox
What Have We Learned from the Brain Map Project So Far? with Tom Nowakowski, UCSF
Quality Healthcare Should Not Depend on Which Book Club You Attend, Karen Tumulty of the Washington Post
Real Probiotics: Colleen Cutcliffe, CEO, Pendulum Therapeutics
Todd Druley of Mission Bio on Single Cell Multi-Omics
Kevin Davies on Gene Therapy in 2023
History and State of Proteomics 2023 with John Yates
New Philosophy of Biology Series on PBS: A Preview with Host Robert Lawrence Kuhn
Mapping the Meta Proteome: John Shon, CTO, Serimmune
Supercharged Killer Cells Effective Against Alzheimer’s: Paul Song, CEO, NKGen Biotech
Chris Hall and Rich Chen of Personalis on Next Gen MRD Testing
State of Sequencing 2023: Shawn Baker and Keith Robison
Newborn Sequencing 2023 Part II: What Evidence Is Enough?
Lincoln Nadauld on the State of Precision Medicine in 2023
Nothing Is "Undruggable:" Alex Federation, CEO, Talus Bio
Mass Spec Advances in a New Age of Proteomics: Rosy Lee, Thermo Fisher Scientific
This Is Very Cool: Treating Cancer with Sound
The Future of Clinical Proteomics with Jenny Van Eyk and Daniel Hornburg
Elinor Karlsson on Darwin’s Ark
Long DNA for Difficult Applications: Dan Lin-Arlow, CEO, Ansa Biotech
Next Gen CRISPR Therapies with Trevor Martin, CEO of Mammoth Biosciences
13th Season Opener: Mike Snyder on Microsampling and Multi-Omic Profiling
Gene Patent Decision at 10 Years, State of Genetic Testing with Ellen Matloff, My Gene Counsel
Proteomics Bigger than Genomics, It’s Just Taking Time, Says Jeff Hawkins, CEO, Quantum-SI
Biden, AI, and DeSci: John Cumbers Previews SynBioBeta 2023
Proteomics Today Where Genomics Was in the 80s: Margaret Donovan and Asim Siddiqui of Seer on Landmark Study
Is This New Platform an Answer to the Reproducibility Crisis? with Guy Rohkin
Elegen Pioneers Long DNA Subindustry with CEO Matt Hill
Nevermind the $200 Genome, Element CEO Molly He Says Core Chemistry Capable of Much More
3D Genomics Solves Cancer Case Where Sequencing Came Up Short: Anthony Schmitt, Arima Genomics
New Spatial Company Maps Cell Surface Proteome without Imaging
John Greally on His Latest Review of Epigenomics
President of ASHG on Eugenics Apology, Diversity Initiative
23andMe Launches New Personalized Healthcare Initiative with Amy Sturm
Converting Digital to Biological: John Gill, Telesis Bio
50% Not Tested: Precision Oncology with Jerome Madison, Invitae
Paul Freemont on Synthetic Biology in the UK
The Bioengineered Hangover Cure: Changing the Conversation around GMOs with Zack Abbott of ZBiotics